PMID: 22581593May 15, 2012Paper

Factors affecting the quality of life in hemifacial spasm patients

Neurologia i neurochirurgia polska
Monika RudzińskaAndrzej Szczudlik

Abstract

Hemifacial spasm (HFS), a movement disorder manifested by unilateral spasms of the muscles innervated by the facial nerve, interferes with social life in about 90% of patients, causing social isolation and depression and having a significant impact on the quality of life. The aim of the study was to assess factors affecting the quality of life in patients with HFS in respect of influence of the severity of depression symptoms and botulinum toxin type A (BTX-A) therapy. Eighty-five out of 129 patients included in the HFS database of the Movement Disorders Outpatient Clinic, Department of Neurology, University Hospital, Cracow who fulfilled the inclusion criteria and had no exclusion criteria (suffering from concomitant movement disorders, other severe chronic diseases or cognitive impairment) were studied. Demographic and clinical data (age at onset, disease duration and accompanying symptoms) were collected. Severity of HFS was assessed by the five-point clinical scale and seven-point Clinical Global Impression scale. Quality of life was assessed with the HFS-36 questionnaire and severity of depressive symptoms was evaluated with the Beck Depression Inventory. HFS-36 was performed twice, before BTX-A injection and two weeks lat...Continue Reading

References

Mar 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·E K Tan, J Jankovic
Jul 19, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·R HilkerJ Rudolf
Apr 24, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·Y Ben-ShlomoUNKNOWN ESDE collaborative group
Jul 26, 2002·Journal of Neurology·J MüllerUNKNOWN Austrian Botulinum Toxin and Dystonia Study Group
Feb 8, 2003·Journal of Neurology·W GerschlagerK P Bhatia
Jun 18, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·A J CarsonM Sharpe
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Nov 18, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·L S WilliamsK Kroenke
Dec 16, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Anette SchragNiall Quinn
Mar 31, 2004·Journal of the Neurological Sciences·Eng-King TanErle Lim
Jun 16, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Marcin ZachMirosława Derejko
Dec 15, 2004·Acta Neurologica Scandinavica·J ReimerG H Franke
May 10, 2005·Parkinsonism & Related Disorders·Eng-King TanLeslie Lim
Nov 18, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·E K TanJ Thumboo
Feb 28, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Anette SchragUNKNOWN European MSA-Study Group
Jun 27, 2006·Journal of the Neurological Sciences·Anette Schrag
Oct 18, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Eng-King TanSau-Ying Lum
Mar 16, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·K HeuserE Dietrichs
Aug 22, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·I M SkogseidE Kerty
Mar 11, 2008·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Steven Paul WoodsAlexander I Tröster
Jun 3, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Elin Bjelland ForsaaGuido Alves
Jun 28, 2008·Clinical Neurology and Neurosurgery·Eng-King TanLing-Ling Chan
Nov 11, 2008·Clinical Neurology and Neurosurgery·Tatjana PekmezovicVladimir S Kostic
Jan 22, 2009·Journal of Neurology·L LewisM Jahanshahi
Jun 27, 2009·General Hospital Psychiatry·C Allyson JonesScott B Patten
Jul 31, 2009·Parkinsonism & Related Disorders·Natasa KlepacVladimir Trkulja
Aug 12, 2009·Clinical Neurology and Neurosurgery·Zhaohui QinUNKNOWN Chinese Parkinson Study Group
Dec 10, 2009·The Journal of Neuropsychiatry and Clinical Neurosciences·Rosa Quelhas, Manuela Costa
Dec 22, 2009·Parkinsonism & Related Disorders·Yaroslav WinterAlla Guekht
Jan 12, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Kirsten Müller-VahlWolfgang H Oertel

❮ Previous
Next ❯

Citations

Jul 22, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Raymond F SekulaMarion A Hughes
Aug 28, 2019·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Midori H OsakiSuely K N Marie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Eng-King Tan, Ling-Ling Chan
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
Suwanna SetthawatcharawanichKanitpong Phabphal
Acta Neurologica Scandinavica
E-K Tan, L L Chan
© 2021 Meta ULC. All rights reserved